US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Scienture Holdings, Inc.

0.8613

-0.0831-8.80%

Volume:64.40K

Turnover:57.48K

Market Cap:10.78M

PE:0.32

High:0.9534

Open:0.9450

Low:0.8446

Close:0.9444

Loading ...

Overview Company News Filings

BRIEF-Scienture Announces Manufacturing And Supply Chain Readiness For ArbliTM, (Losartan Potassium) Oral Suspension, 10Mg/Ml For A Target Product Launch In July 2025

Scienture initiates supply chain activities by subsidiary to launch Arbli

SCIENTURE announces manufacturing and supply chain readiness for ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL for a target product launch in July 2025.

Scienture Announces Manufacturing and Supply Chain Readiness for Arblitm, (Losartan Potassium) Oral Suspension, 10Mg/Ml for a Target Product Launch in July 2025.

THOMSON REUTERS

Scienture Sells 3 Subsidiaries to Tollo Health for $5 Million

MT Newswires Live

BRIEF-Scienture Announces The Divestiture Of Its Legacy Subsidiaries

Scienture Holdings Inc - Proposed Deal for Total Consideration of $5 Mln

THOMSON REUTERS

Scienture Announces the Divestiture of Its Legacy Subsidiaries for a Total Consideration of $5 Million and Dedicates Its Full Focus to the Branded and Specialty Pharma Segment Through Scienture, Llc.

THOMSON REUTERS

SCIENTURE announces the divestiture of its legacy subsidiaries for a total consideration of $5 million and dedicates its full focus to the Branded and Specialty Pharma segment through Scienture, LLC.

BRIEF-Scienture Holdings Files Prospectus Relates To Resale From Time To Time Of Up To 2.6 Million Shares Of Common Stock By Selling Stockholders

Scienture files to sell 2.64M shares of common stock for holders

Scienture CEO says focused on execution, growth, expansion for years ahead

Scienture Holdings, Inc. Issues Annual Letter to Shareholders

Scienture appoints Rath as CCO, enters agreement with Syneos

SCIENTURE Announces Commercial Operations Leadership and Strategic Agreement with Syneos Health, a leading Contract Sales Organization

Scienture announces draaw on Equity Line of Credit

Scienture Holdings Inc - to Launch Arbli in U.S. in Q3 2025

THOMSON REUTERS

Scienture Holdings Announces Draw on Eloc, Temporarily Suspends Further Draws Until Reaching $10/Share or 30 Trading Days

THOMSON REUTERS

Scienture Says US FDA Approves Oral Liquid Formulation of Hypertension Drug Losartan

MT Newswires Live

Scienture Announces the U.S. FDA Approval of Its Nda for Scn-102, to Be Launched as Arblitm, (Losartan Potassium) Oral Suspension, 10Mg/Ml. the Global Market for Losartan Potassium Was Approximately $1.5 Billion in Sales in 2024.

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SCNX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SCNX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCNX\",,,,,undefined,":{"symbol":"SCNX","market":"US","secType":"STK","nameCN":"Scienture Holdings, Inc.","latestPrice":0.8613,"timestamp":1746025509742,"preClose":0.9444,"halted":0,"volume":64395,"delay":0,"floatShares":8240718,"shares":12515019,"eps":2.681155,"marketStatus":"Trading","change":-0.0831,"latestTime":"04-30 11:05:19 EDT","open":0.945,"high":0.9534,"low":0.8446,"amount":57480.512176799995,"amplitude":0.115205,"askPrice":0.878,"askSize":100,"bidPrice":0.78,"bidSize":100,"shortable":0,"etf":0,"ttmEps":2.681155,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746043200000},"marketStatusCode":2,"adr":0,"listingDate":1581570000000,"exchange":"NASDAQ","adjPreClose":0.9444,"preHourTrading":{"tag":"盘前","latestPrice":0.98,"preClose":0.9444,"latestTime":"09:23 EDT","volume":202,"amount":201.0877074,"timestamp":1746019407853},"postHourTrading":{"tag":"盘后","latestPrice":0.94,"preClose":0.9444,"latestTime":"17:29 EDT","volume":366,"amount":342.8615,"timestamp":1745962155426},"volumeRatio":3.524587},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCNX\",,,,,undefined,":{"symbol":"SCNX","floatShares":8240718,"roa":"-15.65%","roe":"-45.83%","lyrEps":2.685903,"volumeRatio":3.524587,"shares":12515019,"dividePrice":0,"high":0.9534,"amplitude":0.115205,"preClose":0.9444,"low":0.8446,"week52Low":0.69,"pbRate":"0.14","psRate":"78.89","week52High":23.77,"institutionHeld":0,"latestPrice":0.8613,"eps":2.681155,"divideRate":0,"volume":64395,"delay":0,"ttmEps":2.681155,"open":0.945,"prevYearClose":6.05,"prevWeekClose":0.99,"prevMonthClose":1.44,"prevQuarterClose":1.44,"fiveDayClose":0.878,"twentyDayClose":1.34,"sixtyDayClose":3.9},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SCNX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529049043","title":"BRIEF-Scienture Announces Manufacturing And Supply Chain Readiness For ArbliTM, (Losartan Potassium) Oral Suspension, 10Mg/Ml For A Target Product Launch In July 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2529049043","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529049043?lang=en_us&edition=fundamental","pubTime":"2025-04-22 20:48","pubTimestamp":1745326110,"startTime":"0","endTime":"0","summary":"BRIEF-Scienture Announces Manufacturing And Supply Chain Readiness For ArbliTM, (Losartan Potassium) Oral Suspension, 10Mg/Ml For A Target Product Launch In July 2025April 22 (Reuters) - Scienture Hol","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250422:nTUA7BQGS5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2529306926","title":"Scienture initiates supply chain activities by subsidiary to launch Arbli","url":"https://stock-news.laohu8.com/highlight/detail?id=2529306926","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529306926?lang=en_us&edition=fundamental","pubTime":"2025-04-22 20:15","pubTimestamp":1745324115,"startTime":"0","endTime":"0","summary":"Scienture (SCNX) announces the initiation of supply chain activities by its wholly owned subsidiary Scienture to manufacture launch quantities of A...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scienture-initiates-supply-chain-activities-by-subsidiary-to-launch-arbli?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scienture-initiates-supply-chain-activities-by-subsidiary-to-launch-arbli?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","SCNX"],"gpt_icon":0},{"id":"2529309304","title":"SCIENTURE announces manufacturing and supply chain readiness for ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL for a target product launch in July 2025.","url":"https://stock-news.laohu8.com/highlight/detail?id=2529309304","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529309304?lang=en_us&edition=fundamental","pubTime":"2025-04-22 20:05","pubTimestamp":1745323500,"startTime":"0","endTime":"0","summary":"TAMPA, FL, April 22, 2025  -- SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through developing, bringing to market, and distributing novel specialty products to satisfy unmet market needs, is pleased to announce the initiation of supply chain activities by its wholly owned subsidiary Scienture, LLC to manufacture launch quantities of ArbliTM  Oral Suspension, 10 mg/mL for the intended commercial launch of the product in July 2025. Scirenture, LLC’s contract manufacturing partner, Saptalis Pharmaceuticals, LLC for ArbliTM has indicated to Scienture that Saptalis has the materials and capabilities to produce the batches and supply product inventory in time for the target commercial launch. In addition, Scienture, LLC has also entered into agreements with strategic partners for warehousing and distributing the product to the market through vari","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/scienture-announces-manufacturing-supply-chain-120500087.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4167","ARB","SCNX"],"gpt_icon":0},{"id":"2529530584","title":"Scienture Announces Manufacturing and Supply Chain Readiness for Arblitm, (Losartan Potassium) Oral Suspension, 10Mg/Ml for a Target Product Launch in July 2025.","url":"https://stock-news.laohu8.com/highlight/detail?id=2529530584","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529530584?lang=en_us&edition=fundamental","pubTime":"2025-04-22 20:04","pubTimestamp":1745323499,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250422:nTUA7BQGS5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","SCNX"],"gpt_icon":0},{"id":"2525816566","title":"Scienture Sells 3 Subsidiaries to Tollo Health for $5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2525816566","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525816566?lang=en_us&edition=fundamental","pubTime":"2025-04-08 22:14","pubTimestamp":1744121691,"startTime":"0","endTime":"0","summary":"Scienture  said Tuesday that it sold its legacy healthcare IT and wholesale operations subsidiaries to Tollo Health for $5 million.The company divested Integra Pharma Solutions, Bonum Health, and Softell to streamline operations, optimize its portfolio, and accelerate growth in the branded and specialty pharma markets.Scienture said it plans to use the sale proceeds to facilitate the high-growth commercial and strategic product development activities at its Scienture LLC subsidiary.Shares of Scienture Holdings were up over 2% in recent trading.Price: 0.95, Change: +0.02, Percent Change: +2.11","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2525890247","title":"BRIEF-Scienture Announces The Divestiture Of Its Legacy Subsidiaries","url":"https://stock-news.laohu8.com/highlight/detail?id=2525890247","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525890247?lang=en_us&edition=fundamental","pubTime":"2025-04-08 21:32","pubTimestamp":1744119171,"startTime":"0","endTime":"0","summary":"BRIEF-Scienture Announces The Divestiture Of Its Legacy SubsidiariesApril 8 (Reuters) - Scienture Holdings Inc SCNX.O:SCIENTURE ANNOUNCES THE DIVESTITURE OF ITS LEGACY SUBSIDIARIES FOR A TOTAL CONSIDE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nFWN3QM1XI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2525993998","title":"Scienture Holdings Inc - Proposed Deal for Total Consideration of $5 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2525993998","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525993998?lang=en_us&edition=fundamental","pubTime":"2025-04-08 20:05","pubTimestamp":1744113906,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nFWN3QM1XI:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2525289939","title":"Scienture Announces the Divestiture of Its Legacy Subsidiaries for a Total Consideration of $5 Million and Dedicates Its Full Focus to the Branded and Specialty Pharma Segment Through Scienture, Llc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2525289939","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525289939?lang=en_us&edition=fundamental","pubTime":"2025-04-08 20:05","pubTimestamp":1744113906,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nFWN3QM1XI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2525891985","title":"SCIENTURE announces the divestiture of its legacy subsidiaries for a total consideration of $5 million and dedicates its full focus to the Branded and Specialty Pharma segment through Scienture, LLC.","url":"https://stock-news.laohu8.com/highlight/detail?id=2525891985","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525891985?lang=en_us&edition=fundamental","pubTime":"2025-04-08 20:05","pubTimestamp":1744113900,"startTime":"0","endTime":"0","summary":"TAMPA, FL, April 08, 2025  -- SCIENTURE HOLDINGS, INC.  , a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through developing, bringing to market, and distributing novel specialty products to satisfy unmet market needs, announced the divestiture of its legacy Healthcare IT and Wholesale Operations subsidiaries Integra Pharma Solutions , Bonum Health, Inc., and Softell, Inc. to Tollo Health, Inc. for a total consideration of $5 million.The divestitures are part of a broader strategic realignment at the Company designed to sharpen operational focus and unlock long-term value. It is aligned with the Company’s commitment to streamline its core operations, optimize its portfolio, and accelerate growth in the Branded and Specialty Pharma markets. The Company intends to use the proceeds obtained from the divestment to facilitate the high-growth commercial and strategic product development a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/scienture-announces-divestiture-legacy-subsidiaries-120500992.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SCNX","IPS","BK4167"],"gpt_icon":0},{"id":"2525020755","title":"BRIEF-Scienture Holdings Files Prospectus Relates To Resale From Time To Time Of Up To 2.6 Million Shares Of Common Stock By Selling Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2525020755","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525020755?lang=en_us&edition=fundamental","pubTime":"2025-04-05 05:59","pubTimestamp":1743803954,"startTime":"0","endTime":"0","summary":"BRIEF-Scienture Holdings Files Prospectus Relates To Resale From Time To Time Of Up To 2.6 Million Shares Of Common Stock By Selling StockholdersApril 4  - Scienture Holdings Inc SCNX.O:SCIENTURE HOLDINGS FILES PROSPECTUS RELATES TO RESALE FROM TIME TO TIME OF UP TO 2.6 MILLION SHARES OF COMMON STOCK BY SELLING STOCKHOLDERSSource text: [ID:n0001641172-25-002814]Further company coverage: SCNX.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250404:nFWN3QI1L7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"gpt_icon":0},{"id":"2525753960","title":"Scienture files to sell 2.64M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2525753960","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525753960?lang=en_us&edition=fundamental","pubTime":"2025-04-05 05:15","pubTimestamp":1743801346,"startTime":"0","endTime":"0","summary":"17:13 EDT Scienture (SCNX) files to sell 2.64M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, ma...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scienture-files-to-sell-2-64m-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scienture-files-to-sell-2-64m-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2524251913","title":"Scienture CEO says focused on execution, growth, expansion for years ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2524251913","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524251913?lang=en_us&edition=fundamental","pubTime":"2025-04-03 20:36","pubTimestamp":1743683806,"startTime":"0","endTime":"0","summary":"SCIENTURE (SCNX) HOLDINGS provided an annual update from CEO, Surendra Ajjarapu, to its stockholders, which read in part, “This time last year, Sci...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scienture-ceo-says-focused-on-execution-growth-expansion-for-years-ahead?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scienture-ceo-says-focused-on-execution-growth-expansion-for-years-ahead?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","SCNX"],"gpt_icon":0},{"id":"2524251140","title":"Scienture Holdings, Inc. Issues Annual Letter to Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2524251140","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524251140?lang=en_us&edition=fundamental","pubTime":"2025-04-03 20:26","pubTimestamp":1743683160,"startTime":"0","endTime":"0","summary":"TAMPA, FL, April 03, 2025  -- SCIENTURE HOLDINGS, INC.  a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through developing, bringing to market, and distributing novel specialty products to satisfy unmet market needs, is pleased to provide this annual update from its Chief Executive Officer, Surendra Ajjarapu, to its stockholders.Scienture, LLC  was founded in June 2019 as a branded specialty pharmaceutical company with a mission to address critical gaps in patient care by challenging treatment paradigms, product safety and efficacy limitations, access and adherence hurdles, to deliver better patient solutions. It is committed to creating value by developing robust in-house platforms, acquiring or in-licensing differentiated products and nuanced commercialization, that address the needs of patients and caregi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/scienture-holdings-inc-issues-annual-122600011.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4167","SCNX"],"gpt_icon":0},{"id":"2522881894","title":"Scienture appoints Rath as CCO, enters agreement with Syneos","url":"https://stock-news.laohu8.com/highlight/detail?id=2522881894","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522881894?lang=en_us&edition=fundamental","pubTime":"2025-03-26 02:37","pubTimestamp":1742927874,"startTime":"0","endTime":"0","summary":"Scienture (SCNX) announces Michele Rath as Senior Vice President and Chief Commercial Officer, CCO, of Scienture. Under Rath’s leadership, Scientur...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scienture-appoints-rath-as-cco-enters-agreement-with-syneos?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scienture-appoints-rath-as-cco-enters-agreement-with-syneos?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2506951792.HKD","SCNX","LU2249611893.SGD","LU2294711713.HKD","LU0823414478.USD","BK4167","LU2357125470.USD","BK4009","LU0823414551.USD","CCO"],"gpt_icon":0},{"id":"2522883027","title":"SCIENTURE Announces Commercial Operations Leadership and Strategic Agreement with Syneos Health, a leading Contract Sales Organization","url":"https://stock-news.laohu8.com/highlight/detail?id=2522883027","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522883027?lang=en_us&edition=fundamental","pubTime":"2025-03-25 20:05","pubTimestamp":1742904300,"startTime":"0","endTime":"0","summary":"TAMPA, FL, March  25, 2025  (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (the “Company”), a holding company for existing and planned pharmaceutical operating companies focused on provid","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/25/3048696/0/en/SCIENTURE-Announces-Commercial-Operations-Leadership-and-Strategic-Agreement-with-Syneos-Health-a-leading-Contract-Sales-Organization.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2249611893.SGD","SCNX","BK4009","LU0823414478.USD","BK4167","LU2294711713.HKD","LU2506951792.HKD","LU2357125470.USD","CCO","LU0823414551.USD"],"gpt_icon":0},{"id":"2520186925","title":"Scienture announces draaw on Equity Line of Credit","url":"https://stock-news.laohu8.com/highlight/detail?id=2520186925","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520186925?lang=en_us&edition=fundamental","pubTime":"2025-03-19 20:16","pubTimestamp":1742386586,"startTime":"0","endTime":"0","summary":"SCIENTURE (SCNX) HOLDINGS has completed a draw on its Equity Line of Credit to support the commercial launch of Arbli Oral Suspension, while simult...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scienture-announces-draaw-on-equity-line-of-credit?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scienture-announces-draaw-on-equity-line-of-credit?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SCNX","BK4585","EQR","BK4167","BK4588","BK4215"],"gpt_icon":0},{"id":"2520418354","title":"Scienture Holdings Inc - to Launch Arbli in U.S. in Q3 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2520418354","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520418354?lang=en_us&edition=fundamental","pubTime":"2025-03-19 20:05","pubTimestamp":1742385909,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nFWN3Q20CV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","SCNX"],"gpt_icon":0},{"id":"2520183515","title":"Scienture Holdings Announces Draw on Eloc, Temporarily Suspends Further Draws Until Reaching $10/Share or 30 Trading Days","url":"https://stock-news.laohu8.com/highlight/detail?id=2520183515","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520183515?lang=en_us&edition=fundamental","pubTime":"2025-03-19 20:05","pubTimestamp":1742385909,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nFWN3Q20CV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","SCNX"],"gpt_icon":0},{"id":"2520671951","title":"Scienture Says US FDA Approves Oral Liquid Formulation of Hypertension Drug Losartan","url":"https://stock-news.laohu8.com/highlight/detail?id=2520671951","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520671951?lang=en_us&edition=fundamental","pubTime":"2025-03-18 21:03","pubTimestamp":1742303008,"startTime":"0","endTime":"0","summary":"Scienture  said Tuesday the US Food and Drug Administration approved its new drug application for Arbli, an oral suspension formulation of hypertension drug losartan potassium.The company said Arbli is indicated for hypertension in patients older than 6 years old, stroke risk reduction in patients with hypertension and left ventricular hypertrophy, and diabetic nephropathy in certain patients with type 2 diabetes.The company also said the product has two patents and is expected to be listed in the FDA's Orange Book.Scienture said it plans to launch Arbli in the US in Q3.Shares of the company were up more than 24% in recent Tuesday premarket activity.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SCNX","BK4167"],"gpt_icon":0},{"id":"2520627073","title":"Scienture Announces the U.S. FDA Approval of Its Nda for Scn-102, to Be Launched as Arblitm, (Losartan Potassium) Oral Suspension, 10Mg/Ml. the Global Market for Losartan Potassium Was Approximately $1.5 Billion in Sales in 2024.","url":"https://stock-news.laohu8.com/highlight/detail?id=2520627073","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520627073?lang=en_us&edition=fundamental","pubTime":"2025-03-18 20:05","pubTimestamp":1742299500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nTUAV7TGK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","SCNX"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":42,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SCNX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-26","symbol":"SCNX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1742961600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-11-06","symbol":"SCNX","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"pre","actualEps":-1.34},{"market":"US","date":"2024-08-09","symbol":"SCNX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"post","actualEps":null},{"date":"2024-07-19","symbol":"SCNX","amount":1.5,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-07-19","defaultRemindTime":1721395800000,"name":"Trxade Group, Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-24","payableDate":"2024-07-19","currency":"USD","dateTimestamp":1721361600000,"payDate":"2024-07-24"},{"market":"US","date":"2024-06-26","symbol":"SCNX","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1719374400000,"reportTimeType":"","actualEps":-6.4}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SCNX\",market:\"US\",,,undefined,":[{"executeDate":"2024-03-25","recordDate":"2024-03-18","paymentDate":"2024-03-22","value":8,"currency":"USD"},{"executeDate":"2024-07-19","recordDate":"2024-07-19","paymentDate":"2024-07-24","value":1.5,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SCNX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SCNX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SCNX","date":"2025-04-29","current":1.39427,"percent":0.537415,"low":-4.335221,"twenty":-0.575112,"median":1.313069,"eighty":3.100673,"high":3.580326,"avg":1.003943,"sd":2.09805,"marketCap":12640169},"quantilePoints":[{"date":"2024-09-27","current":-0.598388,"twenty":-0.613397,"median":-0.60738,"eighty":-0.601331,"marketCap":10677383},{"date":"2024-10-04","current":-0.575439,"twenty":-0.613397,"median":-0.603293,"eighty":-0.596854,"marketCap":10267882},{"date":"2024-10-11","current":-0.569717,"twenty":-0.610449,"median":-0.596691,"eighty":-0.575112,"marketCap":10165786},{"date":"2024-10-18","current":-3.316594,"twenty":-3.320439,"median":-0.603293,"eighty":-0.579563,"marketCap":59179885},{"date":"2024-10-25","current":-3.532893,"twenty":-3.381003,"median":-0.61388,"eighty":-0.587997,"marketCap":63039443},{"date":"2024-10-31","current":-3.835472,"twenty":-3.470407,"median":-1.920019,"eighty":-0.593421,"marketCap":68438535},{"date":"2024-11-08","current":-3.92083,"twenty":-3.680939,"median":-3.316594,"eighty":-0.596527,"marketCap":69961625},{"date":"2024-11-15","current":3.401097,"twenty":-3.547313,"median":-1.920019,"eighty":-0.574948,"marketCap":68584767},{"date":"2024-11-22","current":3.456572,"twenty":-3.511744,"median":-0.611468,"eighty":3.395976,"marketCap":69703464},{"date":"2024-11-29","current":3.136519,"twenty":-3.477174,"median":-0.603293,"eighty":3.362691,"marketCap":63249440},{"date":"2024-12-06","current":3.110915,"twenty":-3.463831,"median":-0.596691,"eighty":3.285878,"marketCap":62733118},{"date":"2024-12-13","current":3.337086,"twenty":-3.450219,"median":-0.582313,"eighty":3.360949,"marketCap":67293962},{"date":"2024-12-20","current":3.469375,"twenty":-3.422821,"median":-0.572987,"eighty":3.384019,"marketCap":69961625},{"date":"2024-12-27","current":2.837803,"twenty":-3.405517,"median":1.134043,"eighty":3.366915,"marketCap":57225683},{"date":"2025-01-03","current":2.561875,"twenty":-3.372831,"median":2.613767,"eighty":3.343052,"marketCap":51661454},{"date":"2025-01-10","current":2.200068,"twenty":-3.341588,"median":2.571818,"eighty":3.331965,"marketCap":44365450},{"date":"2025-01-17","current":1.983099,"twenty":-3.320439,"median":2.304552,"eighty":3.323431,"marketCap":39990159},{"date":"2025-01-24","current":1.820372,"twenty":-3.285831,"median":2.061208,"eighty":3.308922,"marketCap":36708691},{"date":"2025-01-31","current":1.69236,"twenty":-3.231997,"median":1.995032,"eighty":3.279477,"marketCap":34127269},{"date":"2025-02-07","current":1.431997,"twenty":-2.180107,"median":1.896311,"eighty":3.250031,"marketCap":28876920},{"date":"2025-02-14","current":1.375585,"twenty":-0.618263,"median":1.823627,"eighty":3.227841,"marketCap":27739344},{"date":"2025-02-21","current":1.184652,"twenty":-0.615326,"median":1.76613,"eighty":3.213059,"marketCap":23889088},{"date":"2025-02-28","current":1.145598,"twenty":-0.611128,"median":1.69236,"eighty":3.194897,"marketCap":23101536},{"date":"2025-03-07","current":1.045792,"twenty":-0.608474,"median":1.646775,"eighty":3.193463,"marketCap":21088902},{"date":"2025-03-14","current":0.538084,"twenty":-0.602312,"median":1.540482,"eighty":3.184314,"marketCap":10850721},{"date":"2025-03-21","current":0.733356,"twenty":-0.598212,"median":1.425488,"eighty":3.168951,"marketCap":14788483},{"date":"2025-03-28","current":0.715999,"twenty":-0.597181,"median":1.375585,"eighty":3.16127,"marketCap":14438460},{"date":"2025-04-04","current":1.435684,"twenty":-0.595056,"median":1.425488,"eighty":3.153589,"marketCap":13015619},{"date":"2025-04-11","current":1.12784,"twenty":-0.589891,"median":1.375585,"eighty":3.136519,"marketCap":10224770},{"date":"2025-04-17","current":1.246836,"twenty":-0.582313,"median":1.328698,"eighty":3.136519,"marketCap":11303565},{"date":"2025-04-25","current":1.311304,"twenty":-0.575439,"median":1.30873,"eighty":3.110915,"marketCap":11888016},{"date":"2025-04-29","current":1.39427,"twenty":-0.575112,"median":1.313069,"eighty":3.100673,"marketCap":12640169}],"updateTime":1746025520019}}}